When Wayne mentioned the immunotherapies partnership he seemed to allude to potentially a majority sale.
He said we'll have an equity stake which sounds to me like less than a controlling stake.
Happy with that. Drug development is just too expensive and lead times are too long. So uncertain as well. Iterating new adapt products sounds like a much smarter play.
Wonder how Fraser is feeling about it. Could potentially end up working to make money for big pharma again.
- Forums
- ASX - By Stock
- Ann: AGM Live Stream Webinar Registration Open
When Wayne mentioned the immunotherapies partnership he seemed...
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.95 |
Change
0.200(1.01%) |
Mkt cap ! $383.4M |
Open | High | Low | Value | Volume |
$19.95 | $20.00 | $19.83 | $183.2K | 9.187K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25 | $19.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.95 | 472 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25 | 19.750 |
1 | 15 | 19.670 |
1 | 500 | 19.020 |
1 | 500 | 19.010 |
2 | 502 | 19.000 |
Price($) | Vol. | No. |
---|---|---|
20.000 | 1348 | 2 |
20.100 | 100 | 1 |
20.120 | 420 | 1 |
20.400 | 678 | 1 |
20.500 | 4930 | 2 |
Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |